TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T51426	Farnesoid X-activated receptor	B8HW4G	(E)-3-{3-[(4-Benzo[1,3]dioxol-5-yl-benzyl)-cyclohexanecarbonyl-amino]-phenyl}-acrylic acid	Investigative	44399191	C30H29NO5	483.6	C1CCC(CC1)C(=O)N(CC2=CC=C(C=C2)C3=CC4=C(C=C3)OCO4)C5=CC=CC(=C5)/C=C/C(=O)O	EC50 = 222000 nM	Non binder
T51426	Farnesoid X-activated receptor	BAQ3L1	2-[(1S)-1-[2,5-Dioxo-3-(4-phenoxyphenyl)imidazolidin-1-yl]propyl]-3-methylbenzimidazole-5-carboxylic acid	Investigative	137637016	C27H24N4O5	484.5	CC[C@@H](C1=NC2=C(N1C)C=C(C=C2)C(=O)O)N3C(=O)CN(C3=O)C4=CC=C(C=C4)OC5=CC=CC=C5	IC50 = 209500 nM	Non binder
T51426	Farnesoid X-activated receptor	BB9WQ3	(E)-3-[3-[Cyclohexanecarbonyl-[[4-[4-(dimethylamino)phenyl]phenyl]methyl]amino]phenyl]prop-2-enoic acid	Investigative	44399030	C31H34N2O3	482.6	CN(C)C1=CC=C(C=C1)C2=CC=C(C=C2)CN(C3=CC=CC(=C3)/C=C/C(=O)O)C(=O)C4CCCCC4	EC50 = 255000 nM	Non binder
T51426	Farnesoid X-activated receptor	BCS5O3	2-[(1S)-1-[3-(4-Fluorophenyl)-2,5-dioxoimidazolidin-1-yl]-3-methylbutyl]-3-methylbenzimidazole-5-carboxylic acid	Investigative	137655456	C23H23FN4O4	438.5	CC(C)C[C@@H](C1=NC2=C(N1C)C=C(C=C2)C(=O)O)N3C(=O)CN(C3=O)C4=CC=C(C=C4)F	IC50 = 398800 nM	Non binder
T51426	Farnesoid X-activated receptor	BM0NT5	2-[(1S)-1-[2,5-Dioxo-4-(4-phenoxyphenyl)piperazin-1-yl]-3-methylbutyl]-3-methylbenzimidazole-5-carboxylic acid	Investigative	137644316	C30H30N4O5	526.6	CC(C)C[C@@H](C1=NC2=C(N1C)C=C(C=C2)C(=O)O)N3CC(=O)N(CC3=O)C4=CC=C(C=C4)OC5=CC=CC=C5	IC50 = 417500 nM	Non binder
T51426	Farnesoid X-activated receptor	BM94BR	(E)-3-{3-[Cyclohexanecarbonyl-(4-styryl-benzyl)-amino]-phenyl}-acrylic acid	Investigative	44399088	C31H31NO3	465.6	C1CCC(CC1)C(=O)N(CC2=CC=C(C=C2)/C=C/C3=CC=CC=C3)C4=CC=CC(=C4)/C=C/C(=O)O	EC50 = 255000 nM	Non binder